(Q33527462)

English

Tocilizumab in systemic lupus erythematosus: data on safety, preliminary efficacy, and impact on circulating plasma cells from an open-label phase I dosage-escalation study

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

Tocilizumab in systemic lupus erythematosus: data on safety, preliminary efficacy, and impact on circulating plasma cells from an open-label phase I dosage-escalation study (English)

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

0 references

systemic lupus erythematosus

0 references

author name string

Gabor G Illei

1

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

Yuko Shirota

2

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

Cheryl H Yarboro

3

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

Jimmy Daruwalla

4

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

Edward Tackey

5

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

Kazuki Takada

6

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

Thomas Fleisher

7

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

James E Balow

8

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

Peter E Lipsky

9

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

publication date

1 February 2010

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

Arthritis & Rheumatology

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

62

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

542-552

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

Humanized antihuman IL-6 receptor antibody, tocilizumab

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3057537

21 June 2018

Study of active controlled monotherapy used for rheumatoid arthritis, an IL-6 inhibitor (SAMURAI): evidence of clinical and radiographic benefit from an x ray reader-blinded randomised controlled trial of tocilizumab

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3057537

21 June 2018

IL-6: from laboratory to bedside

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3057537

21 June 2018

IL-6 receptor blockage inhibits the onset of autoimmune kidney disease in NZB/W F1 mice

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3057537

21 June 2018

Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3057537

21 June 2018

Interleukin-6 exacerbates glomerulonephritis in (NZB x NZW)F1 mice

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3057537

21 June 2018

Interleukin 6 promotes murine lupus in NZB/NZW F1 mice

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3057537

21 June 2018

The 1982 revised criteria for the classification of systemic lupus erythematosus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3057537

21 June 2018

Elevated levels of endogenous IL-6 in systemic lupus erythematosus. A putative role in pathogenesis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3057537

21 June 2018

In vitro regulation of B cell differentiation by interleukin-6 and soluble CD23 in systemic lupus erythematosus B cell subpopulations and antigen-induced normal B cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3057537

21 June 2018

Effect of interleukin-6 receptor inhibition with tocilizumab in patients with rheumatoid arthritis (OPTION study): a double-blind, placebo-controlled, randomised trial.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3057537

31 October 2018

Combined oral contraceptives in women with systemic lupus erythematosus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3057537

31 October 2018

Cytokine production, serum levels and disease activity in systemic lupus erythematosus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3057537

31 October 2018

Recombinant human erythropoietin modulates erythrocyte complement receptor 1 functional activity in patients with lupus nephritis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3057537

31 October 2018

Cytokine IL-6 and IL-10 as Biomarkers in Systemic Lupus Erythematosus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3057537

31 October 2018

Anti–interleukin-6 receptor antibody therapy favors adrenal androgen secretion in patients with rheumatoid arthritis: A randomized, double-blind, placebo-controlled study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3057537

31 October 2018

The American College of Rheumatology response criteria for systemic lupus erythematosus clinical trials: Measures of overall disease activity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3057537

31 October 2018

Increased excretions of beta2-microglobulin, IL-6, and IL-8 and decreased excretion of Tamm-Horsfall glycoprotein in urine of patients with active lupus nephritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/20112381

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Therapeutic benefit of blocking interleukin-6 activity with an anti-interleukin-6 receptor monoclonal antibody in rheumatoid arthritis: a randomized, double-blind, placebo-controlled, dose-escalation trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/20112381

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reliability and validity of six systems for the clinical assessment of disease activity in systemic lupus erythematosus

1 reference

https://pubmed.ncbi.nlm.nih.gov/20112381

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Age-associated increase in interleukin 6 in MRL/lpr mice

1 reference

https://pubmed.ncbi.nlm.nih.gov/20112381

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Abnormal distribution of IL-6 receptor in aged MRL/lpr mice: elevated expression on B cells and absence on CD4+ cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/20112381

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Serum soluble interleukin-6 receptor in MRL/lpr mice is elevated with age and mediates the interleukin-6 signal

1 reference

https://pubmed.ncbi.nlm.nih.gov/20112381

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Urinary levels of IL-6 in patients with active lupus nephritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/20112381

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Serum and urinary interleukin-6 in systemic lupus erythematosus

1 reference

https://pubmed.ncbi.nlm.nih.gov/20112381

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Experimental study on intramuscular injection of eukaryotic expression vector pcDNA3- IL-6 on BXSB mice

1 reference

https://pubmed.ncbi.nlm.nih.gov/20112381

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Double-blind randomized controlled clinical trial of the interleukin-6 receptor antagonist, tocilizumab, in European patients with rheumatoid arthritis who had an incomplete response to methotrexate

1 reference

https://pubmed.ncbi.nlm.nih.gov/20112381

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Anti-interleukin-6 monoclonal antibody inhibits autoimmune responses in a murine model of systemic lupus erythematosus

1 reference

https://pubmed.ncbi.nlm.nih.gov/20112381

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1002/ART.27221

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33527462&oldid=1978415559"